CSL PEER ANALYSIS

CSL Ltd — metric-by-metric comparison with peers and the industry median

CSLCSL Ltd

🇦🇺 Australia · AU · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

CSLIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	CSL	ROIV	MRNA	RPRX	INCY	INSM	Ind. Median
P/E	29.44	—	—	39.06	16.88●	—	17.91
P/B	2.20●	6.30	4.25	4.69	4.35	34.12	3.51
EV/EBITDA	10.21●	—	—	23.94	10.79	—	14.82
P/S	2.62●	3,454.68	14.16	13.25	4.51	29.34	10.89

Financial Health
Metric	CSL	ROIV	MRNA	RPRX	INCY	INSM	Ind. Median
Current Ratio	2.57	18.37●	2.41	2.66	3.68	4.47	5.90
Debt/Equity	67.4%	2.4%	17.5%	130.0%	0.6%●	106.2%	10.9%
NetDebt/EBITDA	2.22	16.03	1.35	4.91	-2.13●	0.44	1.15

Profitability
Metric	CSL	ROIV	MRNA	RPRX	INCY	INSM	Ind. Median
Net Margin	9.2%	-3,629.2%	-143.6%	33.9%●	26.7%	-144.4%	-125.7%
ROE	7.7%	-6.5%	-36.6%	12.2%	31.1%●	-294.5%	-47.5%
ROA	3.8%	-5.4%	-26.4%	4.4%	21.9%●	-61.0%	-35.8%
EBITDA Margin	32.8%	-3,162.6%	-129.7%	69.6%●	34.9%	-131.9%	-105.8%

Growth + Dividend
Metric	CSL	ROIV	MRNA	RPRX	INCY	INSM	Ind. Median
Rev. Growth	4.8%	-67.7%	-29.1%	7.8%	21.5%	115.1%●	5.1%
NI Growth	-39.4%	—	—	-24.3%	6,631.4%●	—	12.1%
Div. Yield	2.5%●	—	—	1.6%	—	—	0.2%
Payout	103.1%	—	—	46.8%	—	—	0.0%

Valuation
Metric	CSL	SIG	RMD	PME	FPH	SHL	Ind. Median
P/E	29.44	—	20.35	93.49	41.27	19.48●	17.91
P/B	2.20	38.33	4.73	56.42	9.08	1.23●	3.51
EV/EBITDA	10.21	774.74	13.83	115.24	23.29	9.63●	14.82
P/S	2.62	6.63	5.56	91.21	8.27	1.01●	10.89

Financial Health
Metric	CSL	SIG	RMD	PME	FPH	SHL	Ind. Median
Current Ratio	2.57	1.59	3.01	6.22●	2.31	1.01	5.90
Debt/Equity	67.4%	15.8%	13.0%	1.1%●	6.9%	85.8%	10.9%
NetDebt/EBITDA	2.22	2.82	-0.38	-1.16●	-0.39	3.78	1.15

Profitability
Metric	CSL	SIG	RMD	PME	FPH	SHL	Ind. Median
Net Margin	9.2%	-0.3%	27.4%	97.6%●	20.0%	5.2%	-125.7%
ROE	7.7%	-1.6%	25.2%	76.8%●	23.3%	6.4%	-47.5%
ROA	3.8%	-0.9%	18.6%	56.7%●	17.3%	3.3%	-35.8%
EBITDA Margin	32.8%	0.9%	39.1%	78.4%●	34.9%	17.3%	-105.8%

Growth + Dividend
Metric	CSL	SIG	RMD	PME	FPH	SHL	Ind. Median
Rev. Growth	4.8%	45.7%●	10.5%	30.3%	4.8%	11.4%	5.1%
NI Growth	-39.4%	—	15.9%	138.8%●	-11.6%	-1.1%	12.1%
Div. Yield	2.5%	0.5%	8.0%●	0.3%	1.6%	5.2%	0.2%
Payout	103.1%	-114.0%	22.4%	24.5%	53.9%	96.9%	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on CSL

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 3, 26. This content is for informational purposes only and is not investment advice.